Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Intangibles (2023 - 2025)

Jin Medical International's Intangibles history spans 3 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Intangibles fell 3.84% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $1.1 million, down 3.84%, while the annual FY2025 figure was $1.1 million, 3.84% down from the prior year.
  • Intangibles for Q3 2025 was $1.1 million at Jin Medical International, down from $1.1 million in the prior quarter.
  • Across five years, Intangibles topped out at $1.1 million in Q3 2024 and bottomed at $154364.0 in Q3 2023.
  • The 3-year median for Intangibles is $1.1 million (2025), against an average of $801331.3.
  • The largest annual shift saw Intangibles surged 642.94% in 2024 before it fell 3.84% in 2025.
  • A 3-year view of Intangibles shows it stood at $154364.0 in 2023, then soared by 642.94% to $1.1 million in 2024, then dropped by 3.84% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for ZJYL's Intangibles are $1.1 million (Q3 2025), $1.1 million (Q3 2024), and $154364.0 (Q3 2023).